ArticleJournal of aging research2026
Low-Dose Lemon Myrtle Supplementation Enhances Muscle Hypertrophy in Older Adults Undergoing Low-Load Resistance Training: A Randomized Controlled Trial.
Article in Journal of aging research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Low-Dose Lemon Myrtle Supplementation Enhances Muscle Hypertrophy in Older Adults Undergoing Low-Load Resistance Training: A Randomized Controlled Trial.Journal of aging research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/Objectives: Our previous study showed that a combination of lemon myrtle (LM) leaf extract at the conventional dose (250 mg/day, 2.5 mg/day as casuarinin) and low-load resistance training using body weight led to significantly greater increases in muscle size than resistance training alone. This study aimed to determine whether LM supplementation at half the conventional dose (125 mg/day, 1.25 mg/day as casuarinin), combined with low-load resistance training, could similarly enhance muscle hypertrophy in older adults and to evaluate the persistence of these effects during a detraining period. Methods: This was a randomized, placebo-controlled, double-blind, parallel-group trial. Sixty Japanese men and women aged ≥ 65 years who were aware of age-related declines in muscle strength participated. Participants were randomly assigned to a placebo group or an LM group (receiving 125 mg/day). Both groups performed low-load, bodyweight resistance training twice weekly (three sets of four exercises). Anterior thigh muscle thickness was assessed before and after the 12-week intervention, and after a subsequent 6-week detraining period. Results: The LM group showed a significantly greater increase in anterior thigh muscle thickness than the placebo group. However, LM supplementation did not help maintain muscle hypertrophy during the detraining period. Conclusions: LM supplementation at half the conventional dose enhances skeletal muscle hypertrophy following 12 weeks of low-load resistance training in older adults experiencing muscle strength decline.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.